Adicet BioACET

13F holders, Q3 2025 (September 30)
54holders +5
12new positions
7sold out
3famous investors
$0.81avg. 13F price*

At the end of Q3 2025, 54 institutions reported holding Adicet Bio Inc. (ACET) in their 13F filings, up 5 from Q2 2025. 12 opened new positions and 7 sold out. The largest holders were Orbimed Advisors LLC ($9.3M), Tang Capital Management LLC ($6.7M) and Ra Capital Management, L.P. ($6.1M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Adicet Bio Inc.
CUSIP
007002108
Latest filing quarter
Q1 2026

History

Number of 13F holders

020406080100 Q1 2024: 98Q1 2024Q2 2024: 86Q2 2024Q3 2024: 64Q3 2024Q4 2024: 64Q4 2024Q1 2025: 56Q1 2025Q2 2025: 49Q2 2025Q3 2025: 54Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions12$491K
Exits7$550K

All 13F filers, Q2 2025 → Q3 2025: 2,430,628 shares bought and 2,632,370 shares sold, net −201,742 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 54 holders

Orbimed Advisors LLC 0.22% No change 11,447,140 $9.3M
Tang Capital Management LLC 0.26% No change 8,223,612 $6.7M
Ra Capital Management, L.P. 0.08% No change 7,541,000 $6.1M
Goldman Sachs Group Inc. 0.00% Reduce -0.0% 3,751,617 $3.0M
Vanguard Group Inc. 0.00% No change 3,272,522 $2.7M
Carlyle Group Inc. 0.06% No change 2,948,718 $2.4M
Acadian Asset Management LLC 0.00% Add +9.2% 2,265,491 $1.8M
Renaissance Technologies 0.00% Add +58.5% 1,828,949 $1.5M
Regeneron Pharmaceuticals, Inc. 0.11% No change 968,183 $784K
Bridgeway Capital Management, LLC 0.02% No change 901,600 $730K
Two Sigma Investments, LP 0.00% Add +66.7% 854,568 $692K
Two Sigma Advisers, LP 0.00% Add +38.0% 780,982 $633K
Geode Capital Management, LLC 0.00% No change 706,334 $572K
Alyeska Investment Group, L.P. 0.00% No change 655,665 $531K
RBF Capital, LLC 0.02% No change 617,319 $500K
BlackRock, Inc. 0.00% Reduce -2.4% 585,377 $474K
Citadel Advisors 0.00% Add +26.8% 583,948 $473K
Millennium Management 0.00% Reduce -4.5% 565,953 $459K
Schonfeld Strategic Advisors LLC 0.00% Reduce -74.5% 479,108 $388K
Johnson & Johnson 0.06% No change 364,472 $295K
Wealthedge Investment Advisors, LLC 0.09% Reduce -4.2% 300,054 $243K
Barclays PLC 0.00% Add +100.0% 300,000 $243K
State Street Corp. 0.00% Reduce -1.1% 244,186 $198K
Jane Street Group, LLC 0.00% New 186,200 $151K
Northern Trust Corp. 0.00% No change 140,373 $114K
Vontobel Holding Ltd. 0.00% No change 80,000 $65K
Virtu Financial LLC 0.00% New 79,916 $65K
Royal Bank of Canada 0.00% Add +90934.1% 80,110 $65K
Rangeley Capital, LLC 0.06% New 75,000 $61K
Morgan Stanley 0.00% Add +2.0% 73,682 $60K
Bluefin Capital Management, LLC 0.03% New 66,854 $54K
XTX Topco Ltd 0.00% Add +146.6% 58,139 $47K
Dimensional Fund Advisors LP 0.00% Reduce -7.5% 52,963 $43K
Marshall Wace, LLP 0.00% New 51,733 $42K
Squarepoint Ops LLC 0.00% New 46,427 $38K
Susquehanna International Group, LLP 0.00% New 40,370 $33K
Abacus Planning Group, Inc. 0.00% No change 36,764 $30K
Two Sigma Securities, LLC 0.00% New 25,274 $20K
UBS Group AG 0.00% Add +15.8% 21,438 $17K
Bank of America Corp. 0.00% Reduce -0.1% 20,607 $17K
Qube Research & Technologies Ltd 0.00% Add +1.5% 20,257 $16K
HRT Financial LP 0.00% New 18,627 $15K
Mariner, LLC 0.00% New 14,850 $12K
Raymond James Financial Inc. 0.00% Add +253.5% 13,265 $11K
Tower Research Capital LLC (TRC) 0.00% Reduce -82.8% 4,992 $4K
Hollencrest Capital Management 0.00% No change 2,000 $2K
Toth Financial Advisory Corp. 0.00% No change 1,600 $1K
BNP Paribas Financial Markets 0.00% No change 896 $726
SBI Securities Co., Ltd. 0.00% Add +0.6% 827 $670
FMR LLC 0.00% Reduce -99.7% 776 $629
JPMorgan Chase & Co. 0.00% No change 771 $625
Advisory Services Network, LLC 0.00% New 316 $256
Citigroup Inc. 0.00% Reduce -76.5% 166 $134
Osaic Holdings, Inc. 0.00% New 10 $7

"% of holder's portfolio" is ACET's weight in each manager's 13F, not the share of Adicet Bio Inc. the manager owns.